IDALLO STUDY: A RETROSPECTIVE MULTICENTER STUDY OF THE SFGM-TC EVALUATING THE EFFICACY AND SAFETY OF IVOSIDENIB, IN RELAPSED AML AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

被引：0

作者：

Caillet, Adrien ^{[1
]}

Simonet-Boissard, Marion ^{[1
]}

Forcade, Edouard ^{[2
]}

Robin, Marie ^{[3
]}

Yakoubagha, Ibrahim ^{[4
]}

Maillard, Natacha ^{[5
]}

Deviller, Raynier ^{[6
]}

Couturier, Marie-Anne ^{[7
]}

Huynh, Anne ^{[8
]}

Bourhis, Jean-Henri ^{[9
]}

Simand, Celestine ^{[10
]}

Chantepie, Sylvain ^{[11
]}

Berceanu, Ana ^{[1
]}

机构：

[1] CHU Besancon, Besancon, France

[2] CHU Bordeaux, Bordeaux, France

[3] Hop St Louis, Paris, France

[4] CHRU Lille, Lille, France

[5] CHU Poitiers, Poitiers, France

[6] IPC, Marseille, France

[7] CHU Brest, Brest, France

[8] IUCT, Toulouse, France

[9] IGR, Villejuif, France

[10] ICANS, Strasbourg, France

[11] CHU, Caen, France

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P509

引用

页码：499 / 499

页数：1

共 50 条

[21] Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC
Rey, Gaelle
Daguenet, Elisabeth
Bonjean, Paul
Devillier, Raynier
Fegueux, Nathalie
Forcade, Edouard
Srour, Micha
Chevallier, Patrice
Robin, Marie
Suarez, Felipe
Micol, Jean-Baptiste
Labussiere-Wallet, Helene
Bilger, Karin
Daguindau, Etienne
Bay, Jacques-Olivier
Fayard, Amandine
Bulabois, Claude-Eric
Nguyen-Quoc, Stephanie
Genthon, Alexis
Orvain, Corentin
Turlure, Pascal
Loschi, Michael
Poire, Xavier
Guillerm, Gaelle
Beguin, Yves
Maillard, Natacha
Mear, Jean-Baptiste
Chalayer, Emilie
Cornillon, Jerome
Tavernier, Emmanuelle
BONE MARROW TRANSPLANTATION, 2023, 58 (12) : 1331 - 1338
[22] Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC
Gaëlle Rey
Elisabeth Daguenet
Paul Bonjean
Raynier Devillier
Nathalie Fegueux
Edouard Forcade
Micha Srour
Patrice Chevallier
Marie Robin
Felipe Suarez
Jean-Baptiste Micol
Hélène Labussière-Wallet
Karin Bilger
Etienne Daguindau
Jacques-Olivier Bay
Amandine Fayard
Claude-Eric Bulabois
Stéphanie Nguyen-Quoc
Alexis Genthon
Corentin Orvain
Pascal Turlure
Michael Loschi
Xavier Poiré
Gaëlle Guillerm
Yves Beguin
Natacha Maillard
Jean-Baptiste Mear
Emilie Chalayer
Jérôme Cornillon
Emmanuelle Tavernier
Bone Marrow Transplantation, 2023, 58 : 1331 - 1338
[23] Double haplo-identical and/or cord-blood allogeneic stem cell transplantation in hematologic malignancies: a retrospective study from the SFGM-TC
Cavalieri, Doriane
Pereira, Bruno
Chebel, Reda
Labussiere-Wallet, Helene
Socie, Gerard
Calleja, Anne
Forcade, Edouard
Chevallier, Patrice
Rubio, Marie-Therese
Raus, Nicole
Bay, Jacques-Olivier
Ravinet, Aurelie
BONE MARROW TRANSPLANTATION, 2018, 53 : 742 - 743
[24] Impact of treatment prior to allogeneic stem cell transplantation for myelodysplastic syndromes: A study on behalf of the SFGM-TC and the GFM groups
Damaj, Gandhi Laurent
Duhamel, Alain
Robin, Marie
Michallet, Mauricette
Mohty, Mohamad
Vigouroux, Stephane
Beguin, Yves
Garnier, Alice
Lioure, Bruno
El Cheikh, Jean
Fegueux, Nathalie
Cornillon, Jerome
Francois, Sylvie
Rubio, Marie Therese
Huynh, Anne
Park, Sophie
Marolleau, Jean Pierre
Garnier, Frederico
Fenaux, Pierre
Yakoub-Agha, Ibrahim
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[25] The outcome of DLI in AML/MDS patients relapsed after allogeneic stem cell transplantation: multicentre retrospective study
Moon, J. H.
Sohn, S. K.
Kim, J. G.
Chae, Y. S.
Cho, Y. Y.
Ahn, J. S.
Yang, D. H.
Lee, J. J.
Kim, H. J.
Choi, Y. J.
Shin, H. J.
Jung, J. S.
BONE MARROW TRANSPLANTATION, 2008, 41 : S431 - S432
[26] Managing late-effects after allogeneic stem cell transplantation in children: Recommendations from the SFGM-TC
de Berranger, E.
Michel, G.
Fand, M.
Gandemer, V.
Jubert, C.
Marie-Cardine, A.
Pochon, C.
Rohrlich, P. S.
Sirvent, A.
Cartigny, M.
Deschildre, A.
Yakoub-Agha, I.
PATHOLOGIE BIOLOGIE, 2014, 62 (04): : 212 - 217
[27] Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
Herbaux, Charles
Gauthier, Jordan
Brice, Pauline
Fornecker, Luc
Bouabdallah, Krimo
Manson, Guillaume
Ghesquieres, Herve
Thiebaut-Bertrand, Anne
Demarquette, Helene
Boyle, Eileen
Ysebaert, Loic
Houot, Roch
Yakoub-Agha, Ibrahim
Morschhauser, Franck
BLOOD, 2015, 126 (23)
[28] Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study
Xhaard, Alienor
Xhaard, Constance
D'Aveni, Maud
Salvator, Helene
Chabi-Charvillat, Marie-Laure
Coman, Tereza
Beguin, Yves
Chalandon, Yves
Poire, Xavier
Loschi, Michael
Paillard, Catherine
Bruno, Benedicte
Ceballos, Patrice
Dalle, Jean-Hugues
Bilger, Karin
Bay, Jacques-Olivier
Robin, Marie
N'guyen-Quoc, Stephanie
Rubio, Marie Therese
BLOOD, 2020, 136
[29] Fourth annual series of workshops of the SFGM-TC to harmonize practices in allogeneic stem cell transplantation
Yakoub-Agha, I.
PATHOLOGIE BIOLOGIE, 2014, 62 (04): : 179 - 179
[30] Reduced intensity allogeneic stem cell transplantation in patients with myelodysplastic syndrome: Does the conditioning matter? A retrospective study of the SFGM-TC on 61 patients.
Terriou, L.
Chir, Z.
Esperou, H.
Boiron, J.
Gratecos, N.
Vernant, J.
Michallet, M.
Milpied, N.
Jouet, J.
Yakoub-Agha, I.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 348S - 348S

← 1 2 3 4 5 →